Skip to content

Vaxcyte

US · PCVX #1630 by market cap Listed 2020
55.39 -2.97 -5.09%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Vaxcyte

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Founded
2013
CEO
Mr. Grant E. Pickering
Employees
507
Headquarters
San Carlos, California, United States of America
Fiscal year end
12-31
Website
vaxcyte.com

Company profile

Exchange
US
Symbol
PCVX
Market-cap rank
#1630
Listing date
2020-06-12
Market cap
8.77B
Float cap
8.08B
Shares out
158.30M
Float shares
145.89M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Vaxcyte discussion 0 comments

Add a comment